|
29 May 2020 |
Johnson & Johnson Receives Positive CHMP Opinion for Janssen’s Investigational Preventive Ebola Vaccine Regimen
|
|
29 May 2020 |
Clinical Response and Translational Data from DeCidE1, a Phase 2 Study of DPX-Survivac Immunotherapy in Patients with Advanced Recurrent Ovarian Cancer
|
|
29 May 2020 |
Vaxxas Announces That Merck Exercises Option to Apply Novel Immune System Activation Platform for Vaccine Candidate
|
|
29 May 2020 |
GSK announces intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations
|
|
29 May 2020 |
AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company
|
|
28 May 2020 |
ImmunityBio & NantKwest Sign COVID-19 Joint Development, Manufacturing and Marketing Agreement; ImmunityBio Selected for ‘Operation Warp Speed’ to Develop Novel Adenovirus COVID-19 Vaccine
|
|
28 May 2020 |
Stallergenes Greer and Anergis Report Successful Preclinical Study Results With COP-virosomes as Second-generation Allergen Immunotherapy
|
|
26 May 2020 |
IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2
|
|
26 May 2020 |
Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
|
|
21 May 2020 |
IMV Announces Selection of a Vaccine Candidate Against COVID-19 to Advance Into Human Clinical Studies
|
|
21 May 2020 |
CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine
|
|
21 May 2020 |
AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
|
|
20 May 2020 |
Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate
|
|
20 May 2020 |
INOVIO’s COVID-19 DNA vaccine INO-4800 demonstrates robust neutralizing antibody and T cell immune responses in preclinical models
|
|
19 May 2020 |
PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology
|
|
19 May 2020 |
Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate
|
|
18 May 2020 |
GreenLight Biosciences raises $17M financing round to accelerate large-scale manufacturing of future COVID-19 vaccines
|
|
18 May 2020 |
Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
|
|
15 May 2020 |
Medicago Announces Positive Results in Animal Trials for Its Vaccine Candidate Against COVID-19
|
|
14 May 2020 |
INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo® (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following Treatment
|
|
14 May 2020 |
Pfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age
|
|
14 May 2020 |
CureVac´s Optimized mRNA Platform Provides Positive Pre-Clinical Results at Low Dose for Coronavirus Vaccine Candidate
|
|
14 May 2020 |
VAXIMM Announces First Results from Phase I/II Trial in Progressive Glioblastoma with Oral T-cell Immunotherapy VXM01 in Combination with PD-L1 Inhibitor Avelumab to be Presented at ASCO20 Virtual
|
|
12 May 2020 |
Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
|
|
11 May 2020 |
TolerogenixX Reports Positive Phase Ib Data of its Lead Product to Combat Transplant Rejection
|
